Work

Pilot study of redirected autologous T cells engineered to contain anti-CD19 attached to TCRζ and 4-1BB signaling domains in patients with chemotherapy-resistant or -refractory CD19+ leukemia and lymphoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps10072

Authors: Stephan A. Grupp, David L. Porter, Bruce Levine, Michael Kalos, Christine Strait, Susan R. Rheingold, Richard Aplenc, Carl H. June

Institutions: Children's Hospital of Philadelphia, Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596980997

Cites:

Cited by: 1

Related to: 10